向死而生:新药临床试验过程中的自利逻辑与社会赋义

Being Towards Death:The Logic of Egoism and Social Implications in Clinical Trials

药品的研发生产是一个极其复杂的过程,临床试验则是其中的一个关键环节。临床试验不仅是技术性的,还是社会性的和文化性的,各方参与者在自利主义逻辑下,根据受试身体生物学变量的差异,将健康受试临床试验解释为"身体物质的交易",而将患者受试临床试验理解为"播撒希望的福利"。在社会赋义下,临床试验成了一种道德可接受、目标能理解的社会行动。临床试验的社会赋义在一定程度上弥合了医学技术与社会文化之间的堕距,并体现出受试拒绝将自身看作对象物,要求在社会关系、社会生产之中实现能动性与主体性的社会需求。然而,在这种社会赋义之后,存在一个值得警惕的社会问题,即收入分配与风险分配不平等在低收入群体身上叠加,并使特定群体承担更多的风险。

The social implication of clinical trials bridges the gap between medical technology and the culture to a certain extent,and it reflects the refusal of participates to regard themselves as objects and their requirement to realize initiative and subjectivity in social relations and social production.However,the overlapping of income and risk distribution inequality on low-income social groups behind the social meaning of clinical trials is still a problem.